Renato Naito

720 citations
50 papers · 486 indexed · h-index 11
Topics
Prostate Cancer Treatment and Research (20 papers)Prostate Cancer Diagnosis and Treatment (13 papers)Cancer, Lipids, and Metabolism (11 papers)
Partner nations
JapanUnited StatesTaiwan

In The Last Decade

Renato Naito

41 papers receiving 483 citations

Peers

Renato Naito
Comparison fields: 5 of 76
  • Pulmonary and Respiratory Medicine 235
  • Oncology 180
  • Molecular Biology 112
  • Immunology 108
  • Cancer Research 75
Replace Mark C. Scholz with:
Mark C. Scholz United States
Gabriel Olmedilla Spain
Sagar Sardesai United States
Boxing Su China
Jinchun Xing China
Hang Lv China
Masakatsu Oishi Japan
Peide Bai China
Yu Gan China
Jimeng Hu China
Renato Naito relative to Mark C. Scholz United States Mark C. Scholz's profile →
Citations per field
00.5×2.7×
Mark C. Scholz · 1×
Citations per year

Countries citing papers authored by Renato Naito

Since Specialization
Citations

This map shows the geographic impact of Renato Naito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Naito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Naito more than expected).

Fields of papers citing papers by Renato Naito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Naito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Naito. The network helps show where Renato Naito may publish in the future.

Co-authorship network of co-authors of Renato Naito

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Naito. A scholar is included among the top collaborators of Renato Naito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Naito. Renato Naito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 4
6 0
7 5
8 1
9 1
10 3
11 1
12 0
13 10
14 5
15 2
16 6
17 6
18 6
19 29
20 30

About Renato Naito

Renato Naito is a scholar working on Urology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 50 papers that have together received 486 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Cancer, Lipids, and Metabolism (11 papers). The work is most often cited by research in Urology (59 citations), Pulmonary and Respiratory Medicine (235 citations) and Oncology (180 citations). Renato Naito has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Atsushi Mizokami, Kouji Izumi, Yoshifumi Kadono, Kazuyoshi Shigehara, Hiroaki Iwamoto, Suguru Kadomoto, Tomoyuki Makino, Ariunbold Natsagdorj, Hiroshi Yaegashi and Takahiro Nohara. Their work appears in journals such as Scientific Reports, Molecules and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026